Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
A Toddler With Persistent Crying and a Coin Overlying the Upper Mediastinum.
Journal: Journal of the American College of Emergency Physicians open
Published: May 07, 2026
The impact of non-cardiomyocyte MYBPC3 expression on the development of hypertrophic cardiomyopathy.
The impact of non-cardiomyocyte MYBPC3 expression on the development of hypertrophic cardiomyopathy.
Journal: bioRxiv : the preprint server for biology
Published: May 04, 2026
Loss or Gain: Myosin Heavy Chain Truncations in Hypertrophic Cardiomyopathy.
Journal: Journal of the American Heart Association
Published: October 23, 2025
Targeting Cardiomyocyte PCNA and POLD1 Prevents Pathologic Myocardial Hypertrophy.
Journal: Circulation research
Published: September 15, 2025
Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial.
Journal: Circulation. Heart failure
Published: May 09, 2025
Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial Cardiac Magnetic Resonance Substudy.
Journal: JAMA cardiology
Published: March 05, 2025
Response by Shridhar et al to Letter Regarding Article, "MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy".
Journal: Circulation
Published: August 26, 2024
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial.
Journal: Circulation. Heart failure
Published: August 01, 2024
MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy.
Journal: Circulation
Published: October 27, 2023
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.
Journal: JAMA cardiology
Published: September 06, 2023
Transforming Growth Factor-β Analysis of the VANISH Trial Cohort.
Journal: Circulation. Heart failure
Published: March 31, 2023
Replication Stress Response Modifies Sarcomeric Cardiomyopathy Remodeling.
Journal: Journal of the American Heart Association
Published: July 29, 2021
Last Updated: 09/26/2026